{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T08:02:54Z","timestamp":1777795374440,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"University of the Basque Country","doi-asserted-by":"publisher","award":["19\/306"],"award-info":[{"award-number":["19\/306"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-137848OB-I00"],"award-info":[{"award-number":["PID2022-137848OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT1512\/22"],"award-info":[{"award-number":["IT1512\/22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT211\/19"],"award-info":[{"award-number":["IT211\/19"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jneumeth.2025.110365","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:10:01Z","timestamp":1737198601000},"page":"110365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A method for HDAC activity screening in postmortem human brain. A proof-of-concept study with antipsychotics"],"prefix":"10.1016","volume":"416","author":[{"given":"Oihane","family":"Mart\u00ednez-Peula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Ramos-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Muguruza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2025.110365_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1017\/S1461145713001466","article-title":"Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor","volume":"17","author":"Aoyama","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","article-title":"Tissue concentrations of clozapine and its metabolites in the rat","volume":"9","author":"Baldessarini","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jneumeth.2025.110365_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/medicina60050709","article-title":"Epigenetic and coping mechanisms of stress in affective disorders: a scoping review","volume":"60","author":"Bernad","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.jneumeth.2025.110365_bib4","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10040572","article-title":"Acetyl-CoA metabolism and histone acetylation in the regulation of aging and lifespan","volume":"10","author":"Bradshaw","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jneumeth.2025.110365_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686117","article-title":"Distribution of histone deacetylases 1-11 in the rat brain","volume":"31","author":"Broide","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jneumeth.2025.110365_bib7","article-title":"Basics of enzymatic assays for HTS","author":"Brooks","year":"2012","journal-title":"Assay. Guid. Man."},{"key":"10.1016\/j.jneumeth.2025.110365_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2013.06.021","article-title":"Histone methylation at H3K9; evidence for a restrictive epigenome in schizophrenia","volume":"149","author":"Chase","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneumeth.2025.110365_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpsychires.2015.04.005","article-title":"Evidence of a sex-dependent restrictive epigenome in schizophrenia","volume":"65","author":"Chase","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jneumeth.2025.110365_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1471-4159.2003.01648.x","article-title":"Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5","volume":"85","author":"Chawla","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneumeth.2025.110365_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF02245121","article-title":"Differences between antipsychotic drugs in persistence of brain levels and behavioral effects","volume":"108","author":"Cohen","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jneumeth.2025.110365_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105182","article-title":"Classical HDACs in the regulation of neuroinflammation","volume":"150","author":"Dai","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneumeth.2025.110365_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29922-0","article-title":"Chromatin profiling in human neurons reveals aberrant roles for histone acetylation and BET family proteins in schizophrenia","volume":"13","author":"Farrelly","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneumeth.2025.110365_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.euroneuro.2019.10.013","article-title":"Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: selective biased agonism via G\u03b1i1-proteins","volume":"29","author":"Garc\u00eda-Bea","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12016-022-08956-8","article-title":"Epigenetic dysregulation in autoimmune and inflammatory skin diseases","volume":"63","author":"Gibson","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib16","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1038\/s41467-019-11031-0","article-title":"Neuroepigenetic signatures of age and sex in the living human brain","volume":"10","author":"Gilbert","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneumeth.2025.110365_bib17","article-title":"PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia","volume":"129","author":"Gilbert","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jneumeth.2025.110365_bib18","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jneumeth.2025.110365_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-011112-140216","article-title":"The potential of HDAC inhibitors as cognitive enhancers","volume":"53","author":"Gr\u00e4ff","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2025.110365_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115613","article-title":"Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases","volume":"258","author":"Han","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jneumeth.2025.110365_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuron.2014.01.028","article-title":"SIRT1 in neurodevelopment and brain senescence","volume":"81","author":"Herskovits","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jneumeth.2025.110365_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jneumeth.2025.110365_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nn.4616","article-title":"Antipsychotic-induced Hdac2 transcription via NF-\u03baB leads to synaptic and cognitive side effects","volume":"20","author":"Ibi","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneumeth.2025.110365_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6782872","article-title":"The beneficial roles of SIRT1 in neuroinflammation-related diseases","volume":"2020","author":"Jiao","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jneumeth.2025.110365_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106601","article-title":"Targeting histone deacetylases for heart diseases","volume":"138","author":"Jin","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jneumeth.2025.110365_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40054-2","article-title":"Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET\/CT\/(MRI) with [18F]TFAHA","volume":"9","author":"Laws","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneumeth.2025.110365_bib28","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1471-4159.2004.02569.x","article-title":"Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling","volume":"90","author":"Li","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneumeth.2025.110365_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"Lopresti","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jneumeth.2025.110365_bib30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s43018-024-00777-2","article-title":"Pharmacological targeting of the cancer epigenome","volume":"5","author":"Mabe","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jneumeth.2025.110365_bib31","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1503\/jpn.230054","article-title":"Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"49","author":"Mart\u00ednez-Peula","year":"2024","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jneumeth.2025.110365_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/genes11050556","article-title":"Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability","volume":"11","author":"Milazzo","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.jneumeth.2025.110365_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/NEN.0000000000000190","article-title":"Effects of postmortem interval on biomolecule integrity in the brain","volume":"74","author":"Nagy","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib34","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1087057115598118","article-title":"Development of an ELISA-based HDAC activity assay for characterization of isoform-selective inhibitors","volume":"20","author":"Padige","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jneumeth.2025.110365_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jneumeth.2025.110365_bib36","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","article-title":"Regulation of histone acetylation by autophagy in Parkinson disease","volume":"291","author":"Park","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneumeth.2025.110365_bib37","article-title":"[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer\u2019s disease","volume":"13","author":"Pascoal","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneumeth.2025.110365_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104052","article-title":"Restoring the epigenome in Alzheimer\u2019s disease: advancing HDAC inhibitors as therapeutic agents","volume":"29","author":"Pereira","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jneumeth.2025.110365_bib39","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneumeth.2025.110365_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.41","article-title":"Measuring histone deacetylase inhibition in the brain","volume":"81","author":"Reddy","year":"2018","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2020.03.008","article-title":"Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability","volume":"89","author":"Richetto","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneumeth.2025.110365_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/112_2021_59","article-title":"Role of histone deacetylases in monocyte function in health and chronic inflammatory diseases","volume":"180","author":"Tordera","year":"2021","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1074-5521(02)00305-8","article-title":"A fluorogenic histone deacetylase assay well suited for high-throughput activity screening","volume":"10","author":"Wegener","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jneumeth.2025.110365_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jneumeth.2025.110365_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11409-0","article-title":"Class IIa HDACs regulate learning and memory through dynamic experience-dependent repression of transcription","volume":"10","author":"Zhu","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027025000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027025000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:16:52Z","timestamp":1777493812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027025000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":45,"alternative-id":["S0165027025000068"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2025.110365","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A method for HDAC activity screening in postmortem human brain. A proof-of-concept study with antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2025.110365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110365"}}